報價延遲最少15分鐘:2026/11/03 12:39 EST
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
8.99 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-3.79/-1.53
|
|
企業價值
1.18B
|
| 資產負債 |
|
每股賬面淨值
0.61
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment. |
